CHO Pharma, Inc. (TPEX:6586)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.60
-3.40 (-6.30%)
Apr 29, 2026, 2:00 PM CST

CHO Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
11,55711,02214,83025,20415,3544,575
Upgrade
Market Cap Growth
6.30%-25.68%-41.16%64.15%235.65%3.48%
Upgrade
Enterprise Value
9,5118,56813,94424,03313,9692,948
Upgrade
Last Close Price
54.0051.5069.30137.0083.5024.90
Upgrade
PS Ratio
8075.873078.64-420067.124300.9833148.76
Upgrade
PB Ratio
4.694.014.9917.648.802.33
Upgrade
P/TBV Ratio
5.664.745.8327.0612.443.19
Upgrade
EV/Sales Ratio
-2393.25-400545.333912.9921363.14
Upgrade
Debt / Equity Ratio
0.010.01-0.010.020.02
Upgrade
Net Debt / Equity Ratio
-0.84-0.85-0.87-0.72-0.74-0.76
Upgrade
Net Debt / EBITDA Ratio
8.619.8310.403.186.995.27
Upgrade
Net Debt / FCF Ratio
8.8810.498.883.996.595.55
Upgrade
Asset Turnover
0.000.00-00.000
Upgrade
Quick Ratio
21.3320.4124.576.199.8910.22
Upgrade
Current Ratio
21.8520.8124.936.3910.0610.37
Upgrade
Return on Equity (ROE)
-8.37%-7.41%-13.90%-21.33%-11.11%-14.05%
Upgrade
Return on Assets (ROA)
-5.82%-5.22%-7.17%-12.55%-6.52%-8.47%
Upgrade
Return on Capital Employed (ROCE)
-10.20%-9.00%-9.00%-24.50%-12.00%-15.50%
Upgrade
Earnings Yield
-2.51%-1.93%-2.06%-1.34%-1.34%-6.49%
Upgrade
FCF Yield
-2.50%-2.02%-1.98%-1.03%-1.28%-5.86%
Upgrade
Buyback Yield / Dilution
-3.72%-11.86%-4.00%-0.04%-0.12%-0.36%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.